Birth Diagnosis of HIV Infection on Infants to Reduce Infant Mortality and Monitor for Elimination of Mother-to-Child Transmission.

a Paediatric HIV Diagnostic Syndicate, Wits Health Consortium, Johannesburg, South Africa b Empilweni Services and Research Unit, Department of Paediatrics, Rahima Moosa Mother and Child Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa c National Health Laboratory Service, Johannesburg, South Africa d Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
The Pediatric Infectious Disease Journal (Impact Factor: 3.14). 04/2013; 32(10). DOI: 10.1097/INF.0b013e318290622e
Source: PubMed

ABSTRACT BACKGROUND:: Early initiation of antiretroviral therapy (ART) depends on an early infant diagnosis (EID) and is critical to reduce HIV-related infant mortality. We describe the implementation of a routine Prevention of Mother-to-Child Transmission (PMTCT) program and focus on EID to identify opportunities to improve outcomes. METHODS:: HIV-exposed infants and their mothers were enrolled in a prospective, observational cohort study at a routine, hospital-based PMTCT and HIV treatment service in Johannesburg, South Africa. Infant HIV status was determined by testing samples collected between birth and 6 weeks and searching the national laboratory information system for PCR results of defaulting infants who accessed testing elsewhere. RESULTS:: Of 838 enrolled infants, HIV status was determined for 606 (72.3%) by testing at the study site, 85 (10.1%) by accessing test results from other facilities, 19 (2.3%) by testing stored samples and remained unknown in 128 (15.3%) infants. In total, 38 perinatally HIV-infected infants were identified. Thirty (79%) HIV-infected infants accessed 6-week testing and initiated ART at a median age of 16.0 weeks, but only 14 were in care a median of 68 weeks later and 4 had died. Eight (21%) HIV-infected infants, 2 of whom died, escaped identification by routine testing. Their mothers were younger, more likely to be foreign and accessed less optimal antenatal care. CONCLUSIONS:: Six-week testing delayed ART initiation beyond the time of early HIV-related infant mortality and missed one-fifth of perinatally HIV-infected infants. Earlier diagnosis and improved retention in care are required to reduce infant mortality and accurately measure elimination of MTCT.


Available from: Gayle Sherman, Jun 02, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background:Antiretroviral therapy is often initiated too late to impact early HIV-related infant mortality. Earlier treatment requires an earlier diagnosis, and the currently recommended 6-week HIV polymerase chain reaction (PCR) test needs reconsideration. This study aims to identify (1) optimal testing intervals to maximize the number of perinatal HIV infections diagnosed and (2) programmatic issues that impact diagnosis.Methods:A mathematical model was developed to simulate antiretroviral prophylaxis uptake and health outcomes in 240,000 HIV-exposed South African infants. The model considered routine early testing with 1 PCR (at birth, 6, 10, or 14 weeks of age) and with 2 PCR tests (at birth and at 6, 10, or 14 weeks of age).Results:A single 6-week test would diagnose the same number of perinatal HIV infections as birth testing (P = 0.92) but fewer infections than a 10-week test (P < 0.01). Ten-week testing identifies the highest number of perinatally infected infants (P < 0.01 compared with a single test at all other ages) but does not save additional life years compared with birth testing (P = 0.27). Performing 2 PCR tests (at birth and 10 weeks) would identify the highest number of perinatal infections (P < 0.01 versus a second 6- or 14-week test). However, 25% of perinatal HIV infections would remain undiagnosed, largely because of failure to return PCR test results to caregivers.Conclusions:Six weeks may no longer be the optimal age to diagnose perinatal HIV infections. Two early PCR tests (at birth and 10 weeks) would likely be the ideal diagnostic algorithm, but must be coupled with improved program coverage.
    JAIDS Journal of Acquired Immune Deficiency Syndromes 08/2014; 67(3). DOI:10.1097/QAI.0000000000000307 · 4.39 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Early initiation of combination antiretroviral therapy (ART) in infants below 12 weeks of age reduces morbidity and mortality. A recent report of transient HIV remission in a child beginning ART from the second day of life has focused attention on very early therapy in the first days of life.
    Current Opinion in HIV and AIDS 11/2014; DOI:10.1097/COH.0000000000000117 · 4.39 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Nigeria has one of the highest HIV burdens as well as mother-to-infant transmission rates in the world. A pilot program using polymerase chain reaction (PCR)-based testing of dried blood spot (DBS) specimens was implemented to enable early identification of HIV-infected infants and timely referral and linkage to care. Method: From February 2007 to October 2008, whole blood was collected by finger prick to prepare DBS from infants < 18 months presenting in 6 public mother-and-child health facilities in Lagos, Nigeria. The DBS were tested using Roche Amplicor HIV-1 DNA Test, v1.5. To monitor laboratory testing quality, all of the PCR-positive and 10% of PCR-negative DBS were retested by the same method at another reference laboratory. Three hundred sixty-five randomly selected infants were screened using HIV rapid tests (RT) according to the national algorithm and specimens that were RT-negative and PCR-positive were also tested using Genscreen enzyme-linked immunosorbent assay (EIA) (Biorad, France). The turnaround time (TAT) from sample collection, testing and dispatching of results from each health facility was monitored. Result: A total of 1,273 infants with a median age of 12.6 weeks (1 day to 71.6 weeks) participated in the program and 280 (22.0%) were PCR-positive. HIV transmission levels varied greatly in the different health facilities ranging from 7.1 to 38.4%. Infants aged 48 to 72 weeks had the highest level of PCR-positivity (41.1%). All PCR-positive specimens were confirmed by retesting. The mean turnaround time from DBS collection to returning of the laboratory result to the health facilities was 25 days. Three infants were found to be HIV-antibody negative by rapid tests but were positive by both PCR and the fourth generation EIA. Conclusion The DBS-based PCR program accurately identified all of the HIV-infected infants. However, many programmatic challenges related to the laboratory and TAT were identified.
    AIDS Research and Human Retroviruses 11/2014; 31(4). DOI:10.1089/AID.2014.0159 · 2.46 Impact Factor